Results 141 to 150 of about 46,771 (265)

Apical Hypertrophic Cardiomyopathy in Association with PulmonaryArtery Hypertension

Journal of Cardiovascular and Thoracic Research, 2012
Apical Hypertrophic Cardiomyopathy is an uncommon condition constituting 1% -2% of the cases with Hypertrophic Cardiomyopathy (HCM) diagnosis. We interestingly report two patients with apical hypertrophic cardiomyopathy in association with significant ...
Mehdi Peighambari, Mozghan Parsaei, Anita Sadeghpour, Azin Alizadehasl   +3 more
doaj  

Elevated COMMD1 Contributes to Cardiomyocyte Copper Efflux in Chronic Myocardial Ischemia: Insights From Rhesus Monkey

Cell Proliferation, EarlyView.
Elevated COMMD1 contributes to copper efflux in cardiomyocytes during chronic ischaemia in rhesus monkey hearts, regulated by XIAP through post‐translational modification. Our findings suggest a positive feedback loop among XIAP, COMMD1 and copper efflux, contributing to ischaemic cardiomyocyte loss.
Chen Li, Da Li, Xia Cheng, Xiaoli Yuan, Ning Du, Xin Liao, Xiaorong Feng, Jie Yao, Chenglong Li, Chengxia Xie, Mu Yang   +10 more
wiley   +1 more source

An unusual ST-segment elevation: Apical hypertrophic cardiomyopathy shows the ace up its sleeve

Revista Portuguesa de Cardiologia, 2013
Apical hypertrophic cardiomyopathy is part of the broad clinical and morphologic spectrum of hypertrophic cardiomyopathy. We report a patient with electrocardiographic abnormalities in whom acute coronary syndrome was excluded and apical hypertrophic ...
Francesco de Santis, Amedeo Pergolini, Giordano Zampi, Gaetano Pero, Paolo Giuseppe Pino, Giovanni Minardi   +5 more
doaj  

Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy

Journal of Molecular and Cellular Cardiology Plus
Introduction: Hypertrophic cardiomyopathy (HCM) results from pathogenic variants in sarcomeric protein genes that increase myocyte energy demand and lead to cardiac hypertrophy.
Arpana Vaniya, Anja Karlstaedt, Damla Gulkok, Tilo Thottakara, Yamin Liu, Sili Fan, Hannah Eades, Styliani Vakrou, Ryuya Fukunaga, Hilary J. Vernon, Oliver Fiehn, M. Roselle Abraham   +11 more
doaj  

Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis

European Journal of Clinical Investigation, EarlyView.
In this systematic review and meta‐analysis assessing the prognostic relevance of cardiac imaging parameters on adverse outcomes in patients with Fabry disease, we found that late gadolinium enhancement, left atrium volume indexed, E/e′ ratio, left ventricular (LV) mass indexed, maximum LV wall thickness and LV‐global longitudinal strain were ...
Kamil Stankowski, Stefano Figliozzi, Thanakorn Rojanathagoon, Dimitrios Bampatsias, Dimitrios Klettas, Lorenzo Monti, Renato Bragato, Pier‐Giorgio Masci, Marco Francone, Gianluigi Condorelli, Massimo Imbriaco, Maurizio Pieroni, Antonia Camporeale, Georgios Georgiopoulos   +13 more
wiley   +1 more source

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

Nature Communications, 2022
Bradley A. Maron, Rui-Sheng Wang, Sergei Shevtsov, Stavros G. Drakos, Elena Arons, Omar Wever-Pinzon, Gordon S. Huggins, Andriy O. Samokhin, William M. Oldham, Yasmine Aguib, Magdi H. Yacoub, Ethan J. Rowin, Barry J. Maron, Martin S. Maron, Joseph Loscalzo   +14 more
doaj   +1 more source

Atrial Fibrillation (AF) and Heart Failure With Preserved Ejection Fraction (HFpEF): Advances and Challenges

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT This state‐of‐the‐art review is based on the Philippe Coumel Lecture in 2024 (Figure 1). It highlights the confluence of two major cardiovascular epidemics, atrial fibrillation and heart failure, with preserved ejection fraction. In these conditions, advances in electrophysiology and heart failure physiology are intertwined and are integrated ...
Sanjeev Saksena, April Slee, Ranghadham Nagarakanti, Atul Prakash   +3 more
wiley   +1 more source

Trends in Research on Hypertrophic Cardiomyopathy and Mitochondria From 2003 to 2023: A Bibliometric Analysis. [PDF]

Health Sci Rep
Yang L, Zhang H, Zhu Z, Wang J, Liu X, Lu L, Huang J, Wang M, Zhu Z.   +8 more
europepmc   +1 more source

Implantable Defibrillators: Which Is the Best Device for Each Patient?

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT The first viable alternative to surgical implantation of an epicardial defibrillator system for secondary prevention of sudden cardiac death (SCD) was a single chamber transvenous implantable cardioverter defibrillator (ICD). Thanks to technological advancements over the past 40 years, electrophysiologists now have several options when ...
Graham Peigh, Bradley P. Knight
wiley   +1 more source

Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy. [PDF]

Biomark Res
Cui H, Wang Y, Hua X, Han J, Mo H, Liu S, Wang H, Huang S, Zhao Y, Chen X, Zhao Q, Jia H, Chang Y, Song J.   +13 more
europepmc   +1 more source